← Back to Search

Ultrasound Therapy

ExAblate for Essential Tremor (ET004 Trial)

N/A
Waitlist Available
Led By Nir Lipsman
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The objective of this study is to evaluate the safety and feasibility of Auto Focusing (AF) echo imaging using the ExAblate Neuro system

Eligible Conditions
  • Essential Tremor
  • Tremor
  • Neurologic Symptoms

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExAblate 4000 SystemExperimental Treatment1 Intervention
ExAblate Neuro system to perform AF echo imaging in treatment of Essential Tremor
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ExAblate
2010
N/A
~130

Find a Location

Who is running the clinical trial?

InSightecLead Sponsor
91 Previous Clinical Trials
3,772 Total Patients Enrolled
12 Trials studying Essential Tremor
1,059 Patients Enrolled for Essential Tremor
Nir LipsmanPrincipal InvestigatorSunnybrook Health Science Centre
~3 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top